28 May, 2017
Following the transaction, the senior vice president now directly owns 26,078 shares in the company, valued at $1,702,632.62. Finally, Achmea Investment Management B.V. bought a new position in AbbVie during the first quarter valued at about $7,865,000.
The stock decreased 0.12% or $0.53 during the last trading session, reaching $455.17. About 277,572 shares traded. (NYSE:ECL) has risen 9.41% since May 26, 2016 and is uptrending. It has underperformed by 63.00% the S&P500.
Stonebridge Cap Advisors Limited Liability Company has invested 2.01% in AbbVie Inc (NYSE:ABBV). It dived, as 86 investors sold AbbVie Inc shares while 555 reduced holdings. The South Street Advisors Llc holds 166,615 shares with $10.43M value, down from 191,320 last quarter.
AbbVie Inc.is a research-based biopharmaceutical company. The stock declined 0.44% or $0.29 reaching $66.03 on the news. Westover Advsr Limited Com invested 0.44% of its portfolio in AbbVie Inc (NYSE:ABBV). It has underperformed by 6.07% the S&P500.
Investors sentiment increased to 1.12 in 2016 Q4.
Since January 1, 0001, it had 0 buys, and 2 insider sales for $612,651 activity.
Several hedge funds have recently made changes to their positions in the stock. The company reported $1.28 EPS for the quarter, topping the Zacks' consensus estimate of $1.26 by $0.02. The Netherlands-based Spf Beheer Bv has invested 3.14% in Ecolab Inc. (NYSE:ECL). Palisade Asset Mngmt Lc reported 26,879 shares or 0.6% of all its holdings. Mycio Wealth Ptnrs invested 0.04% in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). (NYSE:ECL) for 10,658 shares. 93,383 are held by Inv Mngmt Of Virginia Ltd Liability. Lord Abbett & Limited Com, a New Jersey-based fund reported 487,775 shares. Sequoia Financial Ltd Llc owns 3,618 shares for 0.03% of their portfolio. Meritage Gp Inc Lp reported 315,389 shares or 0.53% of all its holdings. Moreover, Van Den Berg Management I Inc has 4.6% invested in the company for 1.08 million shares. Everett Harris Ca reported 91,555 shares. Meeder Asset Management Inc. now owns 97,886 shares of the company's stock worth $6,174,000 after buying an additional 46,693 shares in the last quarter. Legal & General Public Ltd Liability holds 7.61M shares. 5,698 were reported by Armstrong Henry H Assocs. It also reduced General Electric Company (NYSE:GE) stake by 19,137 shares and now owns 104,816 shares. Ten analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company's stock.
Ratings analysis reveals 100% of Colfax's analysts are positive. The stock was sold at an average price of $65.35, for a total value of $2,502,905.00. Ecolab had 28 analyst reports since July 30, 2015 according to SRatingsIntel. The company was maintained on Friday, April 28 by BMO Capital Markets. Deutsche Bank maintained Ecolab Inc. JP Morgan maintained it with "Neutral" rating and GBX 61 target in Tuesday, May 24 report. (NDAQ:REGN), 3 have Buy rating, 0 Sell and 2 Hold. The rating was maintained by Piper Jaffray with "Overweight" on Tuesday, November 3. The firm has "Neutral" rating by Credit Suisse given on Monday, October 31.
10 accumulated 23,504 shares or 0.41% of the stock. The stock of Ecolab Inc.
Analysts await AbbVie Inc (NYSE:ABBV) to report earnings on August, 4. Macquarie Research initiated Ecolab Inc. Barclays Capital has "Equal-Weight" rating and $72 target. The rating was initiated by Sterne Agee CRT on Tuesday, March 22 with "Buy". On Friday, March 10 the insider Schumacher Laura J sold $2.61M. $143,031 worth of stock was sold by HURWICH THOMAS A. on Tuesday, February 28. (NYSE:ECL) was sold by Beck Christophe on Wednesday, May 17.
In other news, Chairman Richard A. Gonzalez sold 72,016 shares of the company's stock in a transaction that occurred on Wednesday, March 8th. $625,500 worth of stock was sold by HIGGINS ARTHUR J on Monday, February 27. Therefore 35% are positive. AbbVie Inc has a one year low of $55.06 and a one year high of $68.12. The stock's average target of $40 is -1.31% below today's ($40.53) share price. Woodstock Corp reported 1.24% in AbbVie Inc (NYSE:ABBV). Jefferies Group LLC reiterated a buy rating and issued a $90.00 price target (up previously from $4.30) on shares of AbbVie in a report on Tuesday, March 7th.
Therapeuticsmd (NYSEMKT:TXMD) had a decrease of 0.75% in short interest. Blackrock Institutional Comm Na invested 0.4% of its portfolio in AbbVie Inc (NYSE:ABBV). The firm has "Buy" rating by Argus Research given on Monday, November 14. About shares traded. AbbVie Inc (NYSE:ABBV) has risen 10.63% since May 26, 2016 and is uptrending. The firm now has a "hold" rating on the stock.
Analysts await AbbVie Inc (NYSE:ABBV) to report earnings on August, 4. Atlantic Securities initiated the stock with "Neutral" rating in Friday, December 18 report.
Since December 2, 2016, it had 0 insider buys, and 9 selling transactions for $19.62 million activity. On Thursday, March 23 Keen Steven R sold $246,297 worth of IDACORP Inc (NYSE:IDA) or 2,966 shares. BMO Capital Markets reissued a "hold" rating and set a $63.00 price target on shares of AbbVie in a report on Wednesday, March 22nd. Stonebridge Capital Advisors LLC now owns 111,235 shares of the company's stock worth $7,248,000 after buying an additional 3,109 shares in the last quarter. The original version of this piece of content can be read at https://www.thestockobserver.com/2017/05/26/abbvie-inc-abbv-shares-sold-by-harvey-investment-co-llc.html.
